Company Info
Phone(408) 585-1700
Year Established
2015
Contacts
Shehnaaz Suliman, M.D., MBA, M.Phil.Link to: David J Lockhart, PhDDAVID J. LOCKHART, Ph.D.CEO
David Lockhart, Ph.D.
President & CSO
Aneele Maki Ph.D.
Senior VP, Business Development
Brandon A. Wustman, Ph.D.
Senior VP, R&D
Max Barker, J.D.
Senior VP, Legal Affairs & Business Operations
Company Description
ReCode Therapeutics is an integrated genetic medicines company developing targeted, disease-modifying therapies for patients with life-limiting respiratory diseases.
